North American Nuclear Medicine Market Worth $2.7 Bn by 2024 – Exclusive Report by MarketsandMarkets™

North American nuclear medicine market
North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period according to a new report by MarketsandMarkets™. The key factors driving the growth of this market are increasing incidence and prevalence of cancer & cardiac ailments and the initiatives to lessen the demand-supply...

Global North American nuclear medicine market : Initiatives to Lessen the Demand-Supply Gap of Mo-99

North American nuclear medicine market
Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent. The North...

North American nuclear medicine market | Professional Analysis, Opportunities, Strategies and Growth Forecast to 2024

North American Nuclear Medicine
The report “North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT – Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) – Forecasts to 2024“, The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2...

How much is the North American Nuclear Medicine Market worth?

North American Nuclear Medicine Industry Overview  The North American Nuclear Medicine market size is expected to reach USD 2.7 billion by 2024, registering a CAGR of 4.1 % over the forecast period, according to a study conducted by MarketsandMarkets. Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives...

Nuclear Medicine/Radiopharmaceuticals Market is is projected to expand at a healthy CAGR of 5.9% by 2023

The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from an estimated USD 3.95 billion in 2018, at a CAGR of 5.9%. Growth in this market is mainly driven by factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. Moreover, the use of radiopharmaceuticals in novel neurological applications...

Nuclear Medicine / Radiopharmaceutical Market expected to reach $5.55 Billion by 2017 at CAGR of 7.8%

The “Healthcare” practice at MarketsandMarkets is pleased to announce its “Analyst Briefing Presentation” on the “Nuclear Medicine/Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) Market – Global Trends & Forecast to 2017”   The...